Recombinant human IFN-alpha 2/IFNA2 protein

Cat No.
IFN0502

Size

QTY

List




Product Information

Product Type
Recombinant Protein
Expression System
E.coli
Domain
24-188aa
UniProt No.
P01563
NCBI Accession No.
NP_000596.2
Alternative names
Interferon alpha 2, IFN-alpha-2, Interferon alpha-A, IFNA, IFN-alphaA, LeIF A, IFNA2A, IFNA2B, IFNA2C, alpha-2a interferon, Interferon alpha 2b

Product Specification

Molecular Weight
19.4 kDa (166aa) confirmed by MALDI-TOF
Concentration
0.5mg/ml (determined by Bradford assay)
Formulation
Liquid in. Phosphate-Buffered Saline (pH 7.4), 10% glycerol
Purity
> 95% by SDS-PAGE
Bioactivity
Measured by its binding ability in a functional ELISA with Human IFN-alpha/beta R2 (CAT# ATGP3952) in the presence of Human IFN-alpha/beta R1 (CAT# ATGP3894).
Endotoxin
< 1 EU per 1ug of protein (determined by LAL method)
Tag
Non-Tagged
Applications
SDS-PAGE, Bioactivity
Storage
Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.

Data

SDS-PAGE

3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain.

Biological Activity

Human IFN-alpha 2 is coated at 10 ug/ml (100 ul/well) can bind Human IFN-alpha/beta R2 (CAT# ATGP3952) in the presence of Human IFN-alpha/beta R1 (CAT# ATGP3894).

Related Publications

    Kim HR, et al. Anti-cancer activity and mechanistic features of a NK cell activating molecule. (Cancer Immunol Immunother. 2009)

Note: For research use only. This product is not intended or approved for human, diagnostics or veterinary use.